The recently completed randomized, double-blind, placebo-controlled trial involved 140 participants, divided into four groups of 35, who were assigned to receive either BluNAD Booster, an NAD precursor, a combination of both, or a placebo. Researchers evaluated the treatment’s impact on NAD-boosting activity through blood biomarkers, physical performance measures, and quality of life assessments.
Initial findings reveal that BluNAD Booster significantly increased NAD levels, with a synergistic effect observed when combined with the NAD precursor. The formula also uniquely balanced NAD-degrading enzymes, enhancing its effectiveness.
This study shows that herbal NAD boosters can significantly support NAD levels, potentially exceeding the efficacy of existing precursors